Sort   by:  
 Page size 
GCN5 interactome in U87MG Control, IR and doxorubicin treated conditions
ORGANISM(S): Homo sapiens (Human) 
2025-05-13 | PXD050400 | Pride
Glioblastoma (GBM) is a malignant grade IV brain tumor, and despite the multimodal therapeutic approaches, which include surgery and chemo-radiotherapy, recurrence is inevitable, arising from therapy-resistant residual cells. To study the residual population's survival mechanism(s), we established a...
ORGANISM(S): Homo sapiens 
Alteration in metabolic repertoire is commonly associated with resistance phenotype. Although it’s a common phenotype, not much efforts have been undertaken to design effective strategies to target the metabolic drift in such cancerous cells and especially with drug resistant properties. In our stud...
ORGANISM(S): Homo sapiens 
Glioblastoma (GBM)is the most aggressive brain tumor with poor overall survival due to high recurrence rate. The recurrent GBM tumors are highly aggressive and resistant to therapy. In the current study, we explored the potential role of Y-box binding protein 3 (YBX3) in glioblastoma aggressiveness....
ORGANISM(S): Homo sapiens 
Anthracyclines, topoisomerase 2 enzyme poison that results in DNA damage, are currently used in acute myeloid leukemia (AML) treatment. Identifying the mechanisms underlying drug resistance remains an important question. Here, using a mitoxantrone-resistant cell line (HL-60/MX2), we found upregulati...
ORGANISM(S): Homo sapiens 
Sort   by:  
 Page size